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A 94-residue polypeptide isolated from human seminal plasma and its chemically synthesized C-terminal 
2%residue segment were studied in an in vitro inhibin bioassay utilizing rat pituitary cell cultures. Both pep- 
tides have previously been claimed to have inhibin activities, and the effects on the secretion and cellular 
content of gonadotrophins (FSH and LH) were now assessed in the in vitro assay. No inhibition was found. 
After 72 h of culture. both the cellular content and the spontaneous as well as the LHRH-stimulated release 
of bioactive or immunoactive FSH and LH remained unaffected. Similarly. no effects were found on the 
storage and/or release of prolactin, growth hormone, or thyrotropin. We conclude that both the native 94- 
residue peptide and the synthetic replicate of its C-terminal 2%residue segment, do not influence the pitui- 
tary FSH secretion when assessed in this in vitro system. 
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1. INTRODUCTION 
It is established that the regulation of the follicle 
stimulating hormone (FSH) secretion from the 
pituitary is partially under the control of a non- 
steroidal gonadal hormone called inhibin [ 1,2]. 
Since the first report of this activity by McCullagh 
[3], many have tried to isolate the active principle 
from different sources [4-61. Two types of peptide 
have been purified from human seminal plasma 
[7,8], the smaller one also occurring in multiple 
size forms apparently because of different 
fragmentations from a parent molecule [9], and 
the larger one with a postulated inhibin activity in 
the C-terminal segment [lo]. Their amino acid se- 
quences [7,1 l-131 revealed them to be unrelated. 
The amino acid sequences also permitted later 
identification of the smaller peptide as one related 
to a major degradation product of a high-M, 
precursor secreted by the seminal vesicles [14], and 
of the larger peptide as a sperm-coating antigen 
[ 121 originating from prostatic epithelium [ 13,151. 
Evidence was also presented for the prostatic 
origin of a closely related immunoreactive material 
1161. 
The inhibin activity of the larger peptide (with 
94 residues) was measured by in vivo assays using 
castrated rats and by in vitro incubations of mouse 
pituitaries [ 111. It was also reported that this pep- 
tide exhibits inhibin activity in a rat pituitary cell 
culture assay. However, this assay was found to be 
less sensitive than the mouse pituitary assay [lo], in 
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contrast to previous reports from others showing 
high sensitivity for the rat pituitary cell culture 
with different crude preparations of inhibin [17]. 
Consequently, the postulated inhibin activity of 
the 94-residue peptide appeared to require further 
analysis. 
Because of all these questions, we decided to in- 
vestigate the activity of the 94-residue peptide, and 
its C-terminal 28residue synthetic replicate [lo], in 
the rat pituitary cell culture bioassay and to com- 
pare the results with the known inhibin activity of 
ovine rete testis fluid, bovine follicular fluid and 
unfractionated human seminal plasma. The effect 
of the peptides on the storage and release of LH, 
FSH and other pituitary hormones was measured. 
No specific effects were detected. However, signs 
of non-specific cell toxicity were recorded in cer- 
tain instances. 
2. MATERIALS AND METHODS 
2.1. Preparations studied 
2.1.1. Native peptide 
The 94-residue peptide was purified by reverse- 
phase high-performance liquid chromatography of 
a partially purified preparation from human 
seminal plasma as described by Sheth et al. [S] and 
identified by analysis of amino acid composition 
and N-terminal residues [8]. 
2.1.2. Synthetic peptides 
Two syntheses of the 28residue C-terminal frag- 
ment of the previously suggested inhibin native 
peptide [lo] were investigated. In one preparation 
(peptide I below), the peptide was synthesized by 
the Merrifield solid-phase method [18], using a 
Beckman 990B peptide synthesizer. After cleavage 
and deprotection, the peptide was desalted on a 
Biogel P-2 column and the crude peptide reduced 
and reoxidized to form the correct disulfide bonds 
[ 191. Final purification was achieved by reverse- 
phase high-performance liquid chromatography. 
An adjacent pool containing a minor fraction of 
the synthetic material was also collected (peptide 
Ia). The correct structure of the pure peptide I was 
verified by complete sequence analysis in a liquid- 
phase sequencer and by amino acid composition 
after hydrolysis. Both analyses gave the expected 
results, proving the correct structure. 
In the other preparation (peptide II), a Mer- 
rifield solid-phase synthesis was carried out as 
above, but the product obtained was not further 
purified. 
2.1.3. Inhibin preparations 
The control preparations used (bovine follicular 
fluid, diluted 1: 1000, and ovine rete testis fluid, 
20.8 U/ml) were gifts from Dr F.J. de Jong 
(Department of Biochemistry, Erasmus Universi- 
ty, Rotterdam, The Netherlands) and Dr D.M. 
Robertson (Department of Anatomy, Monash 
University, Clayton, Victoria, Australia), respec- 
tively. Human seminal plasma was treated with 
charcoal [20]. 
2.2. Pituitary cell culture 
All procedures were performed under sterile 
conditions. Glassware was siliconized and heat- 
sterilized (60 min, 1OO’C). Solutions were steri- 
lized by ultrafiltration through Millipore filters 
(Millex-GS 0.22 ,um). 
Anterior pituitary cells from adult male rats 
were prepared using digestion with trypsin [21] and 
diluted with the incubation medium [Dulbecco’s 
modified Eagles medium (Flow Lab., UK), sup- 
plemented with 5% horse serum and 2.5% fetal 
calf serum (Flow Lab.)]. Aliquots (200 ~1) of about 
150000 cells were cultured in multiwell plates 
(Falcon 3070) at 37°C in a water-saturated at- 
mosphere of 95% sir/5% CO2 for 72 h before the 
addition of any test substance to the medium. 
2.3. Methods for inhibin assays 
2.3.1. Spontaneous release of FSH and LH from 
pituitary cells 
After the 72 h pre-culture, the medium was 
removed and discarded. Fresh aliquots (250~1) of 
culture medium with and without different 
amounts of the test substances were added and the 
cells cultured for another 72 h. The medium was 
then carefully removed and stored at -20°C 
before assay for FSH and LH. 
2.3.2. FSH and LH contents of cells 
After washing the cells once with 0.1% bovine 
serum albumin in Dulbecco’s modified Eagles 
medium, they were lysed by addition of 250~1 of 
0.05 M phosphate-buffered saline containing 
0.1% Triton X-100. The lysate was stored at 
- 20°C. 
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2.3.3. LHRH-stimulated release of FSH and LH 
I20 - After the 72 h culture with the test substance, 
cells were washed and fresh aliquots (2504) of 
80 - 0.1% BSA-Dulbecco’s modified Eagles medium 
i 
added, with or without LHRH (Hoechst, 
D- LO; 10 nmol/l) and containing the same concentrations 
g ill,,,,, * 1111,111 
*G of the test substances as those during the previous 
u FSH RELEASE LH RELEASE 72 h cultures. The cells were then incubated for 
:: 100 - 
another 6 h before removal of the medium for 
;= FSH and LH assays. 
60 - T::w: 
Y 
2.4. Assays of pituitary hormones 
20 - 2.4.1. Radioimmunoassays 
0 L I I I I I, I 11111111 ~ 
Immunoreactive hormones (FSH, LH, GH, 
-13 -10 
10 10 to7 
-13 -10 -7 TSH, PRL) were measured by a double antibody 
10 IO 10 radioimmunoassay (RIA) using reagents provided 
pd CONCENTRATION (mol /I) by the National Institute of Arthritis, Metabolism 
cr 
and Digestive Diseases, National Institute of 
-u_u_ 
Health, Bethesda, USA. The reference prepara- 
31 25.0 310 
tions used were coded: NIAMDD-rat-FSH-RP-1, 
A-A NIAMDD-rat-LH-RP-1, NIADDK-rGH-RP-2 
z VOLUME ADDED OJI) (AFP-319OB), NIADDK-rTSH-RP-2 (AFP-5153B) 
and NIADDK-rPRL-RP-3 (AFP-4459B). 
2.4.2. In vitro bioassay of FSH and LH 
B FSH RELEASE LH RELEASE Activities were measured, using previously 
110 - 
$ so: ++--++ 1: + 1 
described systems [22,23]. 
2.5. CeN toxicity 
E ” 70- 
Cells were assessed for viability by measurement 
:: 
; % 
; -9 
_I 
; of the retention of ?Jr (sodium chromate, Amer- 
. 50 sham, England) according to Robertson et al. [24]. > 
30 
4, 3. RESULTS 
10 
-12 ,09 l$ 10 
-12 ,69 106 3.1. Native 94-residue peptide 
L\ CONCENTRATION (mot/l ) No influence on the LHRH-stimulated im- 
munoreactive or bioactive FSH release was ob- 
1 1 1 I L 1 1 J 
3.1 250 3.1 25 0 
served when the 94-residue native peptide was ap- 
plied in final concentrations ranging from 
A, 0 VOLUME ADDEC (~1) 
Fig. 1. Lack of effect of the 94-residue peptide on the 
LHRH-stimulated release and intracellular content of 
immunoreactive (A) and bioactive (B) FSH and LH. 
Cells were cultured in the presence of different amounts 
of the 94-residue peptide (ti), human seminal 
plasma (o--i)), ovine rete testis fluid (ti) and 
bovine follicular fluid (M), for 72 h, followed by 
6 h in the presence of added LHRH (10 nmol/l). The 
intracellular content of FSH and LH was measured after 
the first culture period in parallel experiments. Levels of 
FSH and LH were measured by RIA (A) or bioassay (B) 
and are expressed as percentages of mean values 
(mean f SD, n = 9) found in control wells without any 
test preparation. The upper scale refers to the peptide 
concentration i log units, the lower scale to the volume 
of reference preparations added. 
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10m6 mol/l co 2.6 x lo-l3 mol/l (fig.1). Shorter of the 9Cresidue peptide (not shown), although the 
culture times than 72 h before the application of control preparations produced a clear effect, less 
LHRH (24 and 48 h) also failed to show any in- pronounced on LH than on FSH. Finally, no sup- 
fluence. Similarly, the peptide did not influence pression of the intracellular content of FSH was 
the LH release (fig.1). However, control prepara- obtained after 72 h of culture with different 
tions of ovine rete testis fluid and bovine follicular amounts of the 94-residue peptide, although a 
fluid employed for the validation of the assay ex- marked inhibition was found with the control 
hibited an inhibitory effect (fig.1). The spon- preparations (fig. 1A). The cellular LH content was 
taneous release of immunoreactive or bioactive not significantly influenced by any of the 
FSH or LH was also not affected by the presence substances tudied (fig.lA). 
A 
FSH RELEASE LH RELEASE 
5 
FSH RELEASE LH RELEASE 
3.1 12.5 50.0 3.1 125 50.0 
VOLUME ADDED (~1) 
Fig.2. Effect of (A) the 28-residue peptide preparations 
and (B) the standard inhibin preparations on 
intracellular content and spontaneous release of 
gonadotrophins. (A) Cultured pituitary &Is were 
treated for 72 h with different doses of the 28-residue 
peptides. (B) Similar experiment, but in this case 
different doses of ovine rete testis fluid (O--O), human 
seminal plasma (M) and bovine follicular fluid 
(H) were used for 72 h. Values are expressed as in 
Fii.3. Test of possible toxic effects of the three 
28-residue peptide preparations on pituitary celIs in 
culture. Pituitary cells were cultured with %r for 48 h, 
the medium was then removed and fresh medium with 
different doses of the synthetic preparations [I (A), Ia 
(0) and II (A)] was added to appropriated wells and the 
cuhure continued for another 72 h. At the end of this 
culture period “Cr was measured in the medium and in 
the cells. Levels of “Cr are expressed as the ratio 
between intra- and extracellular radioactivity (cpm) of 
‘rCr [“Cr(i)/(e)]. Dotted lines represent he limits of 2 
SD, from the mean. Note that the highest concentration 
of preparation Ia was the only one showing toxicity to 
fig. 1. the cells (arrow). 
3.2. Synthetic 28-residue peptide 
None of the synthetic peptide preparations 
showed any inhibin activity when they were ap- 
plied to the pituitary cell culture system (fig.2), ex- 
cept for preparation Ia at the largest dose tested, 
13 x 10V6 mol/l (fig2A). However, at this concen- 
tration, preparation Ia was markedly toxic as 
demonstrated by the poor retention of ‘*Cr (fig.3). 
Since Ia is a side fraction from the purification, it 
is also the material with least amount of authentic 
synthetic peptide. As in the experiments with the 
3 
t 
% RETENTION 
-ttt. .- i 
G 
a: 
1 
t 
.A&““~~ $+A+,AAAA 
_---__---_-------- 
-11 -9 -5 
10 10 lo7 10 
CONCENTRATION (mol/l) 
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CONCENTRATION (mol/O 
Fig.4. Effect of the three 28-residue peptide preparations 
on the prolactin (PRL), thyrotrophin (TSH) and growth 
hormone (GH) content of, and spontaneous release 
from pituitary cells in culture. Cultured cells were 
treated for 72 h with different doses of the 28-residue 
peptides. Values are expressed as in fig.1. 
94-residue peptide, those with the three crude 
preparations of inhibin all showed the expected in- 
hibin effects, with a preferential suppression of the 
FSH rather than the LH release (fig.2B). 
Furthermore, there was no effect of the peptides 
on the release and cellular content of any of the 
other pituitary hormones studied (PRL, TSH and 
GH), except again the toxic effect of preparation 
Ia at the highest concentration (fig.4). In separate 
experiments, as expected, this monolayer pituitary 
cell system was responsive to thyrotropin releasing 
hormone and growth hormone releasing factor 
(not shown) by releasing thyrotropin, prolactin, 
and growth hormone, respectively, in a dose- 
related manner. 
4. DISCUSSION 
Inhibition of spontaneous and LHRH- 
stimulated release of FSH [25] and the suppression 
of the cellular content of FSH [26] are established 
effects of inhibin preparations when they are ap- 
plied to a pituitary cell culture system. In this 
study, preparations used as positive controls in the 
assay (bovine follicular fluid, ovine rete testis fluid 
and human seminal plasma) showed the expected 
[24-281 suppression of FSH cell content and 
release (figs 1,2). However, none of the synthetic 
peptide preparations (I, Ia, II), corresponding to 
the C-terminal segment of the seminal 94-residue 
peptide or the native 94-residue peptide, showed 
any of these properties. Other pituitary hormones 
(GH, TSH, PRL) were also measured in the 
culture medium and in the cells as an index of 
specificity. 
A biphasic dose response relation has been 
reported [lo] concerning the influence of peptides 
on the LHRH-stimulated release of FSH. 
However, considering the large range of concen- 
trations tested here, the possible existence of a 
biphasic response cannot account for the observed 
absence of inhibin activity. 
The sensitivity of the rat pituitary cell culture 
assay has been debated in relation to the assay with 
whole pituitaries or in vivo studies [ 171. However, 
this debate also seems to be irrelevant for the pre- 
sent study because of the absence of inhibin activi- 
ty of the 94-residue peptide at a wide range of con- 
centrations, at the same time as a marked inhibin 
activity of crude preparations from various sources 
was demonstrated. 
The present assay was highly sensitive to LHRH 
stimulation in the sense that the basal secretion of 
FSH was increased 3-5 times (4.4 + 1.3, n = 9) 
after the application of 10 nmol/l of LHRH. This 
is in agreement with previous reports [21]. When 
inhibin activity of the 94-residue peptide and its C- 
terminal segment in a rat pituitary cell culture was 
reported [lo], no description was given of details 
on culture conditions, FSH and LH RIAs or 
number of experiments. Consequently, no detailed 
comparison can be made to find the possible 
reasons for the discrepancy between that study and 
the present one. However, as shown by the present 
data, we consistently find lack of activity under the 
assay conditions described. 
Both direct measurements of cell toxicity by 
determination of “Cr retention and the release of 
hormones showed that peptide Ia damaged the 
cells at the highest concentration. Such evaluation 
of cell damage was not performed in the previous 
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investigations claiming inhibin activity of the pep- 
tides studied [ 10,111. Furthermore, synthetic pep- 
tides [ 11,291, closely related to the 94-residue pep- 
tide and the 28-residue peptide presently studied, 
failed to influence the spontaneous release of FSH 
when they were applied to dispersed pituitary cells 
in culture [2]. 
We conclude therefore that the 94-residue pep- 
tide and its fragment lack inhibin activity. This is 
consistent with present knowledge of the structure 
and origin of the 94-residue peptide. Thus, the 
amino acid sequence shows the peptide to be the 
same as the sperm-coating antigen in human 
seminal plasma [12,13,15]. The site of origin has 
been shown to be prostatic epithelium [ 13,15,16]. 
In addition, the peptide does not disappear from 
peripheral blood after gonadectomy [16,301, and is 
present at high concentrations in gastric secretions 
[31]. None of these properties is expected for a 
hormonal peptide that would regulate FSH secre- 
tion in an inhibin-like manner. Consequently, all 
the properties of the 94-residue peptide, and its 
28-residue C-terminal fragment, harmonize with 
the present demonstration of the absence of in- 
hibin activity. (After the preparation of this 
report, another complete structure was shown for 
inhibin [32], in agreement with several recent isola- 
tions [33-361. This structure also questions 
previous data by demonstrating another structure 
for inhibin, thus confirming our conclusions de- 
rived from direct measurements with the previous 
peptides.) 
ACKNOWLEDGEMENTS 
We are grateful to Dr A.R. Sheth (Institute for 
Research’ in Reproduction, Bombay, India) for 
supplying the seminal plasma preparation. The 
bovine follicular fluid was obtained by courtesy of 
Dr F.H. de Jong (Department of Biochemistry, 
Erasmus University, Rotterdam, The Nether- 
lands), the ovine rete testis reference preparation 
by courtesy of Dr D.M. Robertson (Department of 
Anatomy, Monash University, Clayton, Victoria, 
Australia). We are also grateful to Dr G. Bialy, 
NICHD, Bethesda, MD, USA, for the generous 
supply of the rat RIA reagents. This investigation 
received financial support from the World Health 
Organization’s Special Programme of Research in 
Human Reproduction, the Swedish Cancer Socie- 
ty, the Swedish Medical Research Council, and the 
LEO Research Foundation. S.K. was a recipient of 
a fellowship from the Swedish Institute. 
REFERENCES 
PI 
[21 
131 
[41 
[51 
[61 
171 
181 
191 
1101 
1111 
1121 
[I31 
[I41 
151 
161 
171 
[I81 
Franchimont, P., Chari, S., Hazee-Hagelstein, 
M.T., Debruche, M.L. and Duraiswami, S. (1977) 
in: The Testis in Normal and Infertile Men (Troen, 
P. and Nankin, H.R. eds) pp.253-270, Raven, 
New York. 
De Jong, F.H. and Robertson, D.M. (1985) Mol. 
Cell. Endocrinol. 42, 95-103. 
McCullagh, D.R. (1932) Science 76, 19-20. 
Nandini, S.G., Lipner, H. and Moudgal, N.R. 
(1976) Endocrinology 98, 1960-1965. 
Chari, S., Duraiswari, S. and Franchimont, P. 
(1978) Acta Endocrinol. 87, 434-448. 
Sairam, M.R., Ranganathan, M.R., Ramasharma, 
K. and Lamothe, P. (1981) Mol. Cell. Endocrinol. 
22, 231-250. 
Seidah, N.G., Ramasharma, K., Sairam, M.R. and 
ChrCtien, M. (1984) FEBS Lett. 167, 98-102. 
Sheth, A.R., Arbatti, N., Carlquist, M. and 
Jiirnvall, H. (1984) FEBS Lett. 165, 11-15. 
Li, C.H., Hammonds, R.G. jr, Ramasharma, K. 
and Chung, D. (1985) Proc. Natl. Acad. Sci. USA 
82, 4041-4044. 
Arbatti, N.J., Seidah, N.G., Rochemont, J., 
Escher, E., Sheth, A.R. and ChrCtien, M. (1985) 
FEBS Lett. 181, 57-63. 
Seidah, N.G., Arbatti, N.J., Rochemont, J., 
Sheth, A.R. and ChrCtien, M. (1984) FEBS Lett. 
175, 349-355. 
Johansson, J., Sheth, A.R., Cederlund, E. and 
JGrnvall, H. (1984) FEBS Lett. 176, 21-26. 
Akiyama, K., Yoshioka, Y., Schmid, K., Offner, 
G.D., Troxler, R.F., Tsuda, R. and Hara, M. 
(1985) Biochim. Biophys. Acta 829, 288-294. 
Lilja, H. and Jeppsson, J.-O. (1985) FEBS Lett.’ 
182, 181-184. 
Yoshioka, Y., Akiyama, K., Tsuda, R., Hara, M., 
Schmid, K., Offner, G.D. and Troxler, R.F. (1984) 
Fed. Proc. 43, 1633. 
Beksac, M.S., Khan, S.A., Eliasson, R., 
Skakkebaek, N.E., Sheth, A.R. and Diczfalusy, E. 
(1984) Int. J. Androl. 7, 389-397. 
Hudson, B., Baker, H.W.G., Eddie, L.W., 
Higginson, R.E., Burger, H.G., De Kretser, D.M., 
Dobos, M. and Lee, V. W.K. (1979) J. Reprod. 
Fert. Suppl. 26, 17-29. 
Merrifield, R.B. (1969) Advances Enzym. 32, 
221-296. 
241 
Volume 199, number 2 FEBS LETTERS April 1986 
[19] Gutte, B. and Merrifield, R.B (1971) J. Biol. 
Chem. 246, 1922-1941. 
[20] Baker, H.W.G., Burger, H.G., De Kretser, D.M., 
Eddie, L.W., Higginson, R.E., Hudson, B. and 
Lee, V.W.K. (1978) Int. J. Androl. Suppl. 2, 
115-124. 
[21] Eddie, L. W., Baker, H.W.G., Higginson, R.E. 
and Hudson, B. (1979) J. Endocrinol. 81, 49-60. 
[22] Ritzen, E.M., Froysa, B., Gustafsson, B., 
Westerholm, G. and Diczfalusy, E. (1982) 
Hormone Res. 16, 42-48. 
[23] Van Damme, M.-P., Robertson, D.M. and 
Diczfalusy, E. (1974) Acta Endocrinol. 77, 
655-671. 
[24] Robertson, D.M., Au, C.L. and De Kretser, D.M. 
(1982) Mol. Cell. Endocrinol. 26, 119-127. 
[25] De Jong, F.H., Smith, S.D. and Van Der Molen, 
H.J. (1979) J. Endocrinol. 80, 91-102. 
[26] Scott, R.S., Burger, H.G. and Quigg, H. (1980) 
Endocrinology 107, 1536-1542. 
[27] Main, S.J., Davies, R.V. and Setchell, B.P. (1979) 
J. Reprod. Fert. Suppl. 26, 3-14. 
[28] De Jong, F.H. (1979) Mol. Cell. Endocrinol. 13, 
l-10. 
[29] Ramasharma, K., Sairam, M.R., Seidah, N.G., 
Chretien, M., Manjunath, P., Schiller, P.W., 
Yamashiro, D. and Li, C.H. (1984) Science 223, 
1199-1202. 
[30] Sheth, A.R., Moodbidri, S.B., Bandivdekar, A.H., 
Vanage, G.R., Hurkadli, K.S. and Arbatti, N.J. 
(1984) in: Gonadal Proteins and their Biological 
Significance (Sairam, M.R. and Atkinson, L.E. 
eds) pp.39-48, World Scientific, Singapore. 
[31] Sheth, N.A., Vaze, A.Y. and Sheth, A.R. (1982) 
Clin. Endocrinol. 17, 157-163. 
[32] Mason, A.J., Hayflick, J.S., Ling, N., Esch, F., 
Ueno, N., Ying, S.-Y., Guillemin, R., Niall, H. 
and Seeburg, P.H. (1985) Nature 318, 659-663. 
[33] Robertson, D.M., Foulds, L.M., Leversha, L., 
Morgan, F.J., Hearn, M.T.W., Burger, H.G., 
Wettenhall, R.E.H. and De Kretsen, D.M.V. 
(1985) Biochem. Biophys. Res. Commun. 126, 
220-226. 
[34] Miyamoto, K., Hasegawa, Y., Fukuda, M., 
Nomura, M., Igarashi, M., Kangawa, K. and 
Matsuo, H. (1985) Biochem. Biophys. Res. Com- 
mun. 129, 396-403. 
[35] Rivier, J., Spiess, J., McClintock, R., Vaughan, J. 
and Vale, W. (1985) Biochem. Biophys. Res. Com- 
mun. 133, 120-127. 
[36] Ling, N., Ying, S.-Y., Ueno, N., Esch, F., 
Denoroy, L. and Guillemin, R. (1985) Proc. Natl. 
Acad. Sci. USA 82, 7217-7221. 
248 
